Concord Drugs Ltd — Insider Trading, 01-01-1970: Insider Trading / SAST

The company has announced a board meeting on Saturday, February 10, 2024. The board will consider and approve the financial results for the quarter and half-year. Additionally, they will evaluate proposals for raising funds through various methods like Preferential Issue, Qualified Institutions Placement (QIP), or Rights Issue, or a combination thereof. This move aims to bolster the company's financial position and support future growth initiatives, pending necessary approvals.